secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGEN CORP (NEOG)
CIK:        0000711377
Form:       8-K
Filed at:   2026-10-06T20:05:19+00:00
Accession:  0001193125-26-415544
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Neogen Q1 FY2027 revenue $222.8M, up 6.5%; adjusted EPS $0.08; FY27 revenue and EBITDA guidance raised
--------------------------------------------------------------------------------

- Revenue of $222.8 million, up 6.5% YoY, with core growth of 8.1%; Food Safety revenue rose 7.4% (core growth 8.1%) and Animal Safety rose 4.2% (core growth 8.0%).
- Net loss of $11.9 million, or $(0.05) per share; adjusted net income was $17.5 million and adjusted EPS was $0.08.
- Adjusted EBITDA of $41.6 million at an 18.7% margin; cash flow from operations $12.9 million and free cash flow $4.7 million.
- Neogen is on track to manufacture saleable Petrifilm product and begin its planned multi-quarter manufacturing transition in November 2026, with the first single kit unit (SKU) fully validated.
- Company is raising fiscal year 2027 financial guidance for both revenue and Adjusted EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711377/000119312526415544/0001193125-26-415544-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711377/000119312526415544/neog-20261006.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-415544

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer